HELICOS BIOSCIENCES CORP 4
4 · HELICOS BIOSCIENCES CORP · Filed May 31, 2007
Insider Transaction Report
Form 4
HIGHLAND CAPITAL PARTNERS VI LP
Director10% Owner
Transactions
- Conversion
Series B Preferred Stock
2007-05-30−933,556→ 0 total→ Common Stock (933,556 underlying) - Conversion
Common Stock
2007-05-30+933,556→ 933,556 total - Conversion
Common Stock
2007-05-30+727,937→ 727,937 total - Purchase
Common Stock
2007-05-30$9.00/sh+208,625$1,877,625→ 208,625 total - Conversion
Series A Preferred Stock
2007-05-30−727,937→ 0 total→ Common Stock (727,937 underlying)
Footnotes (2)
- [F1]The preferred stock is convertible at the option of the holder. Upon the closing of the issuer's initial public offering, each share of Series A and B preferred stock automatically converted into common stock on a four and a half-for-one basis.
- [F2]The preferred stock has no expiration date.